Weekly CEO News from Richard Ingram
December 11, 2017

Natural gas prices gapped up a couple percent last evening and held there through much of the day today, settling up just over 2% on the day. Yet prices were not able to continue higher from the gap, raising concerns

Read more

It is indisputable that 2017 has been a challenging year in regards to natural disasters. Hurricane Harvey wrought more than $180 billion in damage to Texas, while Hurricane Maria cost upwards of $95 billion, according to some estimates. With California

Read more

It is indisputable that 2017 has been a challenging year in regards to natural disasters. Hurricane Harvey wrought more than $180 billion in damage to Texas, while Hurricane Maria cost upwards of $95 billion, according to some estimates. With California

Read more

Amazon.com Inc. (Nasdaq: AMZN), the online retail giant, has seen its stock price skyrocket more than 50% over the last 12 months. It has surged past the $1,000 price level, which was tricky to break through, and has continued to

Read more

Leverage, in particular financial leverage, is the amount of debt that an entity uses to buy more assets. In corporate finance, debt financing is a well-known term, which is used as a tool by companies to ensure smooth business operations.

Read more

Video length: 00:14:06 Stocks slowly drift higher today and less than 1% from their all time highs across the board. This is the perfect time to access your risk across all of your trading and investment accounts. Watch this crucial

Read more

At the beginning of 2017, expectations were pretty high that the pharma and biotech sector would finally see lots of mergers and acquisitions (M&As). However, that did not happen. While a few high-value deals were announced, the focus was mostly

Read more

Note: This commentary has been updated to include Friday morning’s release of Nonfarm Employment for November. Official recession calls are the responsibility of the NBER Business Cycle Dating Committee, which is understandably vague about the specific indicators on which they base

Read more

Before the open, Yield10 Bioscience (YTEN) announced it is granting a non-exclusive research license to Monsanto (MON) to evaluate its novel C3003 and C3004 yield traits in soybean. Under the license, Monsanto plans to research both traits within its soybean

Read more

The entire financial and economic narrative in today’s Bubble Finance world is virtually context- and history-free; it’s all about the short-term deltas and therefore exceedingly misleading and dangerous. So when a big trend or condition is negative and unsustainable, you generally can’t even get a glimpse

Read more